[Use of a new long acting local anesthetic, etidocaine in anesthesia-resuscitation (Duranest)].
Our experiment covered 123 patients who were given this new preparation with long action for various types of local and regional anesthesia. In 9 cases of peridural administration for several days, the total doses were very high and tolerance excellent. Results were good for all local and regional anesthesia for which this product was used: - Good local and general tolerance - Short latency period - Duration constantly and regularly prolonged: an average of 3 hours for non-adrenalin forms and 5 hours for adrenalin forms.
D000083:Acetanilides / Q000031:analogs & derivatives; D000328:Adult; D000765:Anesthesia, Conduction / Q000009:adverse effects; D005041:Etidocaine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000083:Acetanilides; D005041:Etidocaine
Utilisation en anesthésie-réanimation d'un nouvel anesthesique local de longue durée d'action, létidocaïne (Duranest)